10.1177/1352458517711568 Mult Scler
Development in the field is competitive and many companies are at varying stages, both clinical and preclinical, for new agonists to target weight loss
Published research context is included to summarize laboratory findings only and does not imply clinical use or therapeutic development
Next, to investigate whether miR-29b-3p regulates GGCT expression, a transfection with miR-29b-3p mimics and inhibitor was performed, and the transfection efficiency was verified (Fig
It could contribute to curbing the increase of obesity-related illnesses, which chop off as many as seven years from the life span
Clear any nasal congestion: Before administering the peptide via spray, clear the nasal membrane